TABLE I.
Demographics, clinical characteristics of 60 patients with 22q11.2DS
| Demographics | Value |
|---|---|
| Female, n (%) | 25 (42) |
| Age (y), median (IQR) | 27 (24–35) |
| Clinical data | |
| BMI (kg/m2) | |
| >25 (overweight) | 33 (56) |
| >30 (obesity) | 15 (25) |
| Cardiovascular conditions, n (%) | |
| Previous heart surgery | 18 (30) |
| Major CHD | 23 (38) |
| Hypertension | 9 (15) |
| DMT | 4 (9) |
| Dyslipidemia | 13 (22) |
| Smoking habit | 11 (19) |
| Psychiatric conditions, n (%) | 39 (65) |
| Neurological conditions, n (%) | 12 (20) |
| Learning issues, n (%) | 45 (76) |
| Autoimmune disorders, n (%) | 25 (42) |
| Thyroiditis | 14 (24) |
| Psoriasis | 5 (8) |
| Autoimmune cytopenias | 3 (5) |
| Alopecia | 2 (3) |
| Arthritis | 1 (2) |
| Immunosuppressive treatment, n (%) | 2 (3) |
| Steroids | 1 (1,5) |
| Tocilizumab | 1 (1,5) |
BMI, Body mass index; DMT, diabetes mellitus.